Qin A, Wu D, Liao J, Xie S, Chen H, Gao Y
Front Pharmacol. 2024; 15:1455979.
PMID: 39386026
PMC: 11463156.
DOI: 10.3389/fphar.2024.1455979.
Chia Y, Siti Asmaa M, Ramli M, Woon P, Johan M, Hassan R
Diagnostics (Basel). 2023; 13(1).
PMID: 36611455
PMC: 9818412.
DOI: 10.3390/diagnostics13010163.
Regimbeau M, Mary R, Hermetet F, Girodon F
Genes (Basel). 2022; 13(4).
PMID: 35456443
PMC: 9027017.
DOI: 10.3390/genes13040637.
Stuckey R, Gomez-Casares M
Int J Mol Sci. 2021; 22(9).
PMID: 34068690
PMC: 8126083.
DOI: 10.3390/ijms22095042.
Rao T, Hansen N, Stetka J, Luque Paz D, Kalmer M, Hilfiker J
Blood. 2021; 137(16):2139-2151.
PMID: 33667305
PMC: 8103999.
DOI: 10.1182/blood.2020005563.
Clonal independence of and or mutations in comutated myeloproliferative neoplasms demonstrated by single cell DNA sequencing.
Thompson E, Nguyen T, Kankanige Y, Yeh P, Ingbritsen M, McBean M
Haematologica. 2020; 106(1):313-315.
PMID: 32817290
PMC: 7776355.
DOI: 10.3324/haematol.2020.260448.
Polycythaemia Vera among Sudanese Patients with Special Emphasis on JAK2 Mutations.
Ibrahim I, Hassan R, Ali E, Omer A
Asian Pac J Cancer Prev. 2019; 20(1):41-44.
PMID: 30677867
PMC: 6485582.
DOI: 10.31557/APJCP.2019.20.1.41.
Detection of Exon 12 and 14 Mutations in Janus Kinase 2 Gene Including a Novel Mutant in V617F Negative Polycythemia Vera Patients from Pakistan.
Akram A, Kausar H, Chaudhary A, Khalid A, Shahzad M, Akhtar M
J Cancer. 2018; 9(23):4341-4345.
PMID: 30519338
PMC: 6277640.
DOI: 10.7150/jca.27414.
Increased B cell activation is present in JAK2V617F-mutated, CALR-mutated and triple-negative essential thrombocythemia.
Lim K, Chen C, Chang Y, Chiang Y, Kao C, Wang W
Oncotarget. 2017; 8(20):32476-32491.
PMID: 28415571
PMC: 5464803.
DOI: 10.18632/oncotarget.16381.
Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms.
Chang Y, Lin H, Chiang Y, Chen C, Huang L, Wang W
Med Oncol. 2017; 34(5):83.
PMID: 28389907
DOI: 10.1007/s12032-017-0944-z.
Genetic-pathologic characterization of myeloproliferative neoplasms.
Kim Y, Park J, Jo I, Lee G, Kim J, Kwon A
Exp Mol Med. 2016; 48:e247.
PMID: 27444979
PMC: 4973314.
DOI: 10.1038/emm.2016.55.
Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b.
Them N, Bagienski K, Berg T, Gisslinger B, Schalling M, Chen D
Am J Hematol. 2014; 90(4):288-94.
PMID: 25545244
PMC: 4657499.
DOI: 10.1002/ajh.23928.
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value.
Vannucchi A, Rotunno G, Bartalucci N, Raugei G, Carrai V, Balliu M
Leukemia. 2014; 28(9):1811-8.
PMID: 24618731
PMC: 4158831.
DOI: 10.1038/leu.2014.100.
Proteomic analysis reveals heat shock protein 70 has a key role in polycythemia Vera.
Gallardo M, Barrio S, Fernandez M, Paradela A, Arenas A, Toldos O
Mol Cancer. 2013; 12:142.
PMID: 24252366
PMC: 4225507.
DOI: 10.1186/1476-4598-12-142.
Inherited predisposition to myeloproliferative neoplasms.
Jones A, Cross N
Ther Adv Hematol. 2013; 4(4):237-53.
PMID: 23926457
PMC: 3734902.
DOI: 10.1177/2040620713489144.
Translating next generation sequencing to practice: opportunities and necessary steps.
Kamalakaran S, Varadan V, Janevski A, Banerjee N, Tuck D, McCombie W
Mol Oncol. 2013; 7(4):743-55.
PMID: 23769412
PMC: 5528427.
DOI: 10.1016/j.molonc.2013.04.008.
Cytogenetics, JAK2 and MPL mutations in polycythemia vera, primary myelofibrosis and essential thrombocythemia.
Caires Dos Santos L, Ribeiro J, Silva N, Cerutti J, da Silva M, Chauffaille M
Rev Bras Hematol Hemoter. 2012; 33(6):417-24.
PMID: 23049357
PMC: 3459377.
DOI: 10.5581/1516-8484.20110116.
JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone.
Godfrey A, Chen E, Pagano F, Ortmann C, Silber Y, Bellosillo B
Blood. 2012; 120(13):2704-7.
PMID: 22898600
PMC: 3672970.
DOI: 10.1182/blood-2012-05-431791.
JAK2 and genomic instability in the myeloproliferative neoplasms: a case of the chicken or the egg?.
Scott L, Rebel V
Am J Hematol. 2012; 87(11):1028-36.
PMID: 22641564
PMC: 3479366.
DOI: 10.1002/ajh.23243.
A highly sensitive quantitative real-time PCR assay for determination of mutant JAK2 exon 12 allele burden.
Kjaer L, Westman M, Riley C, Hogdall E, Bjerrum O, Hasselbalch H
PLoS One. 2012; 7(3):e33100.
PMID: 22403733
PMC: 3293922.
DOI: 10.1371/journal.pone.0033100.